Inovio Pharma (INO) Swings to Q3 Profit
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.09 -0.91%
EPS Growth %: +60.7%
Financial Fact:
Net loss/ (gain) attributable to non-controlling interest: 0
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +60.7%
Financial Fact:
Net loss/ (gain) attributable to non-controlling interest: 0
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q3 EPS of $0.07, versus ($0.12) reported last year. Revenue for the quarter came in at $24.18 million, versus $1.84 million reported last year.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk stock target lifted by Citi on continued demand strength
- Susquehanna lifts Micron stock target to $2,000 after record-breaking quarter
- Commercial Metals (CMC) Tops Q3 EPS by 3c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
